Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Rewind Therapeutics's investors include Boehringer Ingelheim Venture Fund, Sunstone Life Science Ventures, M Ventures, Centre for Drug Design & Discovery (CD3), Gemma Frisius Fund.
Rewind Therapeutics is headquartered in Antwerp, Belgium.
Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.
Rewind Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rewind Therapeutics — Funding & Investors." VCBacked, January 25, 2023, https://www.vcbacked.co/company/rewind-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Rewind Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rewind-therapeutics
{{cite web |title=Rewind Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rewind-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated